- « Previous
- Clinical Pharmacology
- Next »
Xyzal
Clinical Pharmacology
Xyzal
The dose-ranging trial was conducted to evaluate the efficacy of XYZAL 2.5, 5, and 10 mg once daily in the evening. In this trial, each of the three doses of XYZAL demonstrated greater decrease in the reflective pruritus severity score than placebo and the difference was statistically significant for all three doses (see Table 5).
The single dose level trial evaluated the efficacy of XYZAL 5 mg once daily in the evening compared to placebo in patients with chronic idiopathic urticaria over a 4-week treatment period. XYZAL 5 mg demonstrated a greater decrease from baseline in the reflective pruritus severity score than placebo and the difference from placebo was statistically significant.
Duration of pruritus, number and size of wheals, and instantaneous pruritus severity score also showed significant improvement over placebo. The significant improvement in the instantaneous pruritus severity score over placebo confirmed end of dosing interval efficacy (see Table 5).
Table 5: Mean Reflective Pruritus Severity Score in Chronic
Idiopathic Urticaria Trials
| Treatment | N | Baseline | On Treatment Adjusted Mean | Difference from Placebo | ||
| Estimate | 95% CI | p-value | ||||
| Dose-Ranging Trial–Reflective pruritus severity score | ||||||
| XYZAL 2.5 mg | 69 | 2.08 | 1.02 | 0.82 | (0.58, 1.06) | <0.001 |
| XYZAL 5 mg | 62 | 2.07 | 0.92 | 0.91 | (0.66, 1.16) | <0.001 |
| XYZAL 10 mg | 55 | 2.04 | 0.73 | 1.11 | (0.85, 1.37) | <0.001 |
| Placebo | 60 | 2.25 | 1.84 | |||
| Chronic Idiopathic Urticaria Trial –Reflective pruritus severity score | ||||||
| XYZAL 5 mg | 80 | 2.07 | 0.94 | 0.62 | (0.38, 0.86) | <0.001 |
| Placebo | 82 | 2.06 | 1.56 | |||
Pediatric Patients
There are no clinical trials in pediatric patients with chronic idiopathic urticaria [see Use in Specific Populations].
Generic Name: Levocetirizine Dihydrochloride
- « Previous
- Clinical Pharmacology
- Next »
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.
Living with Sinusitis
Millions of Americans suffer with sinusitis. While there are many treatments, it isn't always easy to find the right one for you. See more WebMD Videos »
